Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07835711
Active, not recruiting Not applicable

Strength Training in Archers

NCT07835711 · tracked via the Priya Life Science Turkey tracker
Sponsor
Pınar ATAK ÇAKIR
Phase
Not applicable
Started
2025-12-15
Last updated
2026-09-23

Condition(s) studied

Archery

Investigational drug(s) / intervention(s)

Blood Flow Restriction Biceps CurlIsotonic Biceps CurlNeuromuscular Electrical Stimulation

Blood Flow Restriction Biceps Curl: Participants will perform biceps brachii curl exercise with blood flow restriction. The exercise will consist of 30, 15, 15, and 15 repetitions at 30% of 1-RM, with 30-45 seconds of rest between sets. Blood flow restriction pressure will be determined based on arterial occlusion pressure.

Isotonic Biceps Curl: Participants will perform isotonic biceps brachii curl exercise using resistance corresponding to 60-70% of 1-RM for 3 sets of 12-15 repetitions, with 60 seconds of rest between sets.

Neuromuscular Electrical Stimulation: Participants will receive neuromuscular electrical stimulation targeting the biceps brachii muscle at 60 Hz frequency and 100 μs pulse duration, with 5 seconds of contraction and 5 seconds of rest for a total of 20 minutes.

Study summary

The aim of this study is to compare the acute effects of blood flow restriction resistance exercise, isotonic strengthening exercise, and neuromuscular electrical stimulation applied to the biceps brachii muscle in archery athletes. Volunteer athletes aged 18-45 years, who have been practicing archery for at least one year and have no health restrictions for exercise, will be included in the study. Participants will be divided into three groups and will perform one of the following interventions: blood flow restriction biceps curl, isotonic biceps curl, or NMES.

Warm-up and flexibility exercises will be performed before the interventions. In the blood flow restriction exercise group, a 30-15-15-15 repetition protocol will be performed with a low load under the determined arterial occlusion pressure. In the isotonic exercise group, 3 sets of 12-15 repetitions of biceps curl will be performed at 60-70% of 1-RM. In the NMES group, electrical stimulation will be applied to the biceps brachii muscle for 20 minutes at a frequency of 60 Hz, a pulse duration of 100 µs, and a 5-second contraction/5-second rest protocol.

Participants will be assessed before the intervention, immediately after the intervention, and 15 minutes after the intervention. The viscoelastic properties of the biceps brachii muscle will be assessed using Myoton® PRO; upper-extremity dynamic balance using the Y-Balance Test; upper-extremity endurance using the Modified Push-Up Endurance Test; stabilization using the Upper Extremity Stability Test; and reaction time using the Ruler Drop Test. In addition, demographic characteristics, dominant side, and perceived exertion level will be recorded. The acute effects of the three different interventions on biceps brachii muscle properties and upper-extremity performance parameters will be compared based on the results obtained.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Aged 18-45 years * Having no health problems or restrictions on exercise * Volunteering to participate in the study * Having practiced archery for at least 1 year Exclusion Criteria: * Experiencing an injury during the study * Experiencing symptoms such as dizziness or chest pain during the study * Hypertension (blood pressure \>140/90 mmHg) * Obesity (BMI ≥30 kg/m²) * Presence of varicose veins, deep vein thrombosis, or pulmonary embolism in the participant or a family history of these conditions

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Istanbul Medipol Mega University Hospital Istanbul Turkey (Türkiye)

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07835711 on ClinicalTrials.gov ↗ ← All trials in Turkey